Logo

Geneservice, RNAx

May 18, 2006
Premium

Contract research firm Geneservice and RNAx have launched the PhenoFiler mRNA expression service platform.

According to the companies, the platform provides a solution for profiling tens of thousands of genes and then screening for molecular or cellular phenotypes in a coordinated set of experiments. It combines RNAx's siRNA and shRNA validation technology with Geneservice's gene-expression profiling and network-analysis service.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.